The immune system: Role in hypertension

Canadian Journal of Cardiology

Volumn 29, Issue 5, 2013, Pages 543-548

  Schiffrin, Ernesto L ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; AUTOIMMUNE DISEASE; CHROMOSOME 2; ENDOTHELIAL DYSFUNCTION; HEREDITARY HYPERTENSION; HUMAN; HYPERTENSION; IMMUNE SYSTEM; INNATE IMMUNITY; KIDNEY INJURY; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; OXIDATIVE STRESS; REGULATORY T LYMPHOCYTE; REVIEW; SUPPRESSOR CELL; T LYMPHOCYTE SUBPOPULATION; THROMBOSIS;

ANIMALS; HUMANS; HYPERTENSION; IMMUNE SYSTEM; RATS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 84876794115     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2012.06.009     Document Type: Review

References (43)

1. Virdis A., Schiffrin E.L. Vascular inflammation: a role in vascular disease in hypertension?. Curr Opin Nephrol Hypertens 2003, 12:181-187.
2. Savoia C., Schiffrin E.L. Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions. Clin Sci 2007, 112:375-384.
3. Verlohren S., Muller D.N., Luft F.C., Dechend R. Immunology in hypertension, preeclampsia, and target-organ damage. Hypertension 2009, 54:439-443.
4. Harrison D.G., Guzik T.J., Lob H.E., et al. Inflammation, immunity and hypertension. Hypertension 2011, 57:132-140.
5. De Ciuceis C., Amiri F., Brassard P., Endemann D.H., Touyz R.M., Schiffrin E.L. Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury. Arterioscler Thromb Vasc Biol 2005, 25:2106-2113.
6. Ko E.A., Amiri F., Pandey N.R., Touyz R.M., Schiffrin E.L. Resistance artery remodeling in deoxycorticosterone acetate-salt hypertension is dependent on vascular inflammation: evidence from m-CSF deficient mice. Amer J Physiol Heart Circ Physiol 2007, 292:H1789-H1795.
7. Liu J., Yang F., Yang X.P., Jankowski M., Pagano P.J. NAD(P)H oxidase mediates angiotensin II-induced vascular macrophage infiltration and medial hypertrophy. Arterioscler Thromb Vasc Biol 2003, 23:776-782.
8. Svendsen U.G. Evidence for an initial, thymus independent and a chronic, thymus dependent phase of DOCA and salt hypertension in mice. Acta Pathol Microbiol Scand A 1976, 84:523-528.
9. Olsen F. Transfer of arterial hypertension by splenic cells from DOCA-salt hypertensive and renal hypertensive rats to normotensive recipients. Acta Pathol Microbiol Scand C 1980, 88:1-5.
10. Takeichi N., Suzuki K., Okayasu T., Kobayashi H. Immunological depression in spontaneously hypertensive rats. Clin Exp Immunol 1980, 40:120-126.
11. Rodriguez-Iturbe B., Pons H., Quiroz Y., et al. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. Kidney Int 2001, 59:2222-2232.
12. Crowley S.D., Frey C.W., Gould S.K., et al. Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension. Am J Physiol Renal Physiol 2008, 295:F515-F524.
13. Miossec P., Korn T., Kuchroo V.K. Interleukin-17 and type 17 helper T cells. New Engl J Med 2009, 361:888-898.
14. Hall B.M., Jelbart M.E., Gurley K.E., Dorsch S.E. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Mediation of specific suppression by T helper/inducer cells. J Exp Med 1985, 162:1683-1694.
15. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005, 6:345-352.
16. Vignali D.A., Collison L.W., Workman C.J. How regulatory T cells work. Nat Rev Immunol 2008, 8:523-532.
17. Shao J., Nangaku M., Miyata T., et al. Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury. Hypertension 2003, 42:31-38.
18. Guzik T.J., Hoch N.E., Brown K.A., et al. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 2007, 204:2449-2460.
19. Gratze P., Dechend R., Stocker C., et al. Novel role for inhibitor of differentiation 2 in the genesis of angiotensin II-induced hypertension. Circulation 2008, 117:2645-2656.
20. Madhur M., Lob H.E., McCann L.A., et al. Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension 2010, 55:500-505.
21. Harrison D.G., Guzik T.J., Lob H.E., et al. Inflammation, immunity, and hypertension. Hypertension 2011, 57:132-140.
22. Senchenkova E.Y., Russell J., Kurmaeva E., Ostanin D., Granger D.N. Role of T lymphocytes in angiotensin II-mediated microvascular thrombosis. Hypertension 2011, 58:959-965.
23. Lob H.E., Marvar P.J., Guzik T.J., et al. Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system. Hypertension 2010, 55:277-283.
24. Schiffrin E.L. Vascular remodeling in hypertension: mechanisms and treatment. Hypertension 2012, 59:367-374.
25. Crowley S.D., Song Y., Lin E.E., Griffiths R., Kim H., Ruiz P. Lymphocyte responses exacerbate angiotensin II-dependent hypertension. Am J Physiol Regul Integr Comp Physiol 2010, 298:R1089-R1097.
26. De Miguel C., Lund H., Mattson D. High dietary protein exacerbates hypertension and renal damage in Dahl SS rats by increasing infiltrating immune cells in the kidney. Hypertension 2011, 57:269-274.
27. UCSC Human Gene Sorter Accessed July 14, 2007. http://genome.ucsc.edu/cgi-bin/hgNear.
28. Cowley A.W., Liang M., Roman R.J., Greene A.S., Jacob H.J. Consomic rat model systems for physiological genomics. Acta Physiol Scand 2004, 181:585-592.
29. Viel E.C., Lemarié C.A., Benkirane K., Paradis P., Schiffrin E.L. Immune regulation and vascular inflammation in genetic hypertension. Amer J Physiol Heart Circ Physiol 2010, 298:H938-H944.
30. Barhoumi T., Kasal D.A.B., Li M.W., et al. T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury. Hypertension 2011, 57:469-476.
31. Kvakan H., Kleinewietfeld M., Qadri F., et al. Regulatory T cells ameliorate angiotensin II-induced cardiac damage. Circulation 2009, 119:2904-2912.
32. Kasal D.A.B., Barhoumi T., Li M.W., et al. T regulatory lymphocytes prevent aldosterone-induced vascular injury. Hypertension 2012, 59:324-330.
33. Galkina E., Harry B.L., Ludwig A., et al. CXCR6 promotes atherosclerosis by supporting T-cell homing, interferon-gamma production, and macrophage accumulation in the aortic wall. Circulation 2007, 116:1801-1811.
34. Mallat Z., Ait-Oufella H., Tedgui A. Regulatory T cell responses: potential role in the control of atherosclerosis. Curr Opin Lipidol 2005, 16:518-524.
35. Ait-Oufella H., Salomon B.L., Potteaux S., et al. Natural regulatory cells control the development of atherosclerosis in mice. Nat Med 2006, 12:178-180.
36. Valaperti A., Marty R.R., Kania G., et al. CD11b+ monocytes abrogate Th17 CD4+ T cell-mediated experimental autoimmune myocarditis. J Immunol 2008, 180:2686-2695.
37. Watanabe K., Rao V.P., Poutahidis T., et al. CTLA-4 blockade abrogates protection by regulatory T cells in a mouse model of microbially-induced innate immune-driven colitis. Infect Immun 2008, 76:5834-5842.
38. Kobie J.J., Shah P.R., Yang L., Rebhahn J.A., Fowell D.J., Mosmann T.R. T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5'-adenosine monophosphate to adenosine. J Immunol 2006, 177:6780-6786.
39. Didion S.P., Kinzenbaw D.A., Schrader L.I., Chu Y., Faraci F.M. Endogenous interleukin-10 inhibits angiotensin II-induced vascular dysfunction. Hypertension 2009, 54:619-624.
40. Kassan M., Galan M., Partyka M., Trebak M., Matrougui K. Interleukin-10 released by CD4+CD25+ natural regulatory T cells improves activity in hypertensive mice microvascular endothelial function through inhibition of NADPH oxidase. Arterioscler Thromb Vasc Biol 2011, 31:2534-2542.
41. Ridker P.M., Buring J.E., Shih J., Matias M., Hennekens C.H. Prospective study of C-reactive protein and the risk of future cardiovascular events in apparently healthy women. Circulation 1998, 98:731-733.
42. Blake J.H., Rifai N., Buring J.E., Ridker P.M. Blood pressure, C-reactive protein, and risk of future cardiovascular events. Circulation 2003, 108:2993-2999.
43. Roullet J.B., Xue H., McCarron D.A., Holcomb S., Bennett W.M. Vascular mechanisms of cyclosporin-induced hypertension in the rat. J Clin Invest 1994, 93:2244-2250.